drugset / Trial / NCT04476901
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Phase 2
Recruiting
136 enrolled
Joshua M Hare
The University of Texas Health Science Center, Houston · collabUnited States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.
Timeline
- Start
- 2021-05-07
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic Human Mesenchymal Stem Cells | Cell therapy | 1e+08 cells | Intravenous |